Sage 324 is an oral investigational drug which is thought to enhance the activity of GABA receptors in the brain tremor, having the potential to modulate electrical fluctuations and reduce the abnormal movements in essential tremor. Listen to this podcast with Helen Colquhoun , VP of Development with Sage Therapeutics.
Learn how a DaTscan can help neurologists understand the cause of a patient’s tremors. Mark Hibberd, global head of medical services and chief medical officer of pharmaceutical diagnostics with GE Healthcare, explains.
Madison Young talks about her initial essential tremor diagnosis and how she has learned to explain her condition to others. She expresses her gratitude to those who support the IETF’s scholarship program. “I love having the support of the community behind me,” she said.
How does focused ultrasound work to help manage essential tremor? Listen to our interview with Dr. Arjun Desai, chief strategy and innovation officer with Insightec, a leader in this incisionless technology.
Are you a good candidate for DBS therapy? What are the benefits and risks? Lisa Johanek, senior principal medical affairs scientist with Medtronic, answers these questions and more in our first Talking Essential Tremor podcast.